Caris Life Sciences, Inc. (CAI)
29.53
-0.16
(-0.54%)
USD |
NASDAQ |
Oct 13, 16:00
29.52
-0.01
(-0.03%)
After-Hours: 05:20
Caris Life Sciences Cash from Investing (Quarterly) : -122.19M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.19M |
| March 31, 2026 | -10.34M |
| December 31, 2025 | -5.09M |
| September 30, 2025 | -7.095M |
| June 30, 2025 | -1.386M |
| Date | Value |
|---|---|
| March 31, 2025 | -2.689M |
| December 31, 2024 | -2.29M |
| September 30, 2024 | -1.828M |
| June 30, 2024 | -2.588M |
| March 31, 2024 | 59.64M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CareDx, Inc. | 280.59M |
| Natera, Inc. | -63.43M |
| Myriad Genetics, Inc. | -3.20M |
| BioRestorative Therapies, Inc. | 0.9684M |
| Exagen, Inc. | -0.543M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 28.48M |
| Cash from Financing (Quarterly) | -36.90M |
| Free Cash Flow | 116.25M |
| Free Cash Flow Per Share (Quarterly) | 0.0226 |
| Free Cash Flow to Equity (Quarterly) | -15.04M |
| Free Cash Flow to Firm (Quarterly) | 15.98M |
| Free Cash Flow Yield | 1.39% |